Icahn School of Medicine at Mount Sinai
ASH 2023 Insights: "MyDRUG Sub-Protocol Y3 Results - Selinexor, Ixazomib, Pomalidomide, & Dexamethasone in Functionally High-Risk MM"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Joshua Richter
By
Insights from 2023 ASH Annual Meeting
FEATURING
Joshua Richter
Login to view comments.
Click here to Login